No Detail Found!

South Asian consensus guideline: Use of GLP-1 receptor agonists during ramadan: update 2016.

Author(s)
Faruque Pathan Department of Endocrinology, Osmania Medical College, Hyderabad, India
Zafar Ahmed Latif BIRDEM, Dhaka, Bangladesh
Rakesh Kumar Sahay Osmania Medical College, Hyderabad, India
Abdul Hamid Zargar Advanced Center for Diabetes and Endocrine Care, Srinagar, India
Syed Abbas Raza Shaukat Khanum Memorial Cancer Hospital & Research Centre (SKMCH&RC), Lahore, Pakistan
Azad Khan Diabetic Association of Bangladesh, Bangladesh
Nazrul Islam Siddiqui Mymensingh Medical College, Mymensingh, Bangladesh
Feroz Amin Department of Endocrinology, Osmania Medical College, Hyderabad, India
Noel Somasundaram Diabetes and Endocrine Unit, National Hospital, Colombo, Sri Lanka
Dina Shrestha Department of Endocrinology, Norvic International Hospital, Kathmandu, Nepal
Sanjay Kalra Department of Endocrinology, Bharti Hospital, Karnal, India
Abstract
This guidance is an update to the South Asian Consensus Guideline: Use of GLP1RA in Diabetes during Ramadan, published in the Indian Journal of Endocrinology and Metabolism in 2012. A five country working group has collated evidence and experience to suggest guidelines for the safe and rational use of glucagon-like peptide1 receptor agonists during Ramadan. The suggestions contained herewith are based upon recently published evidence as well as available basic pharmacological data.
Publication Details
Page(s) 774-776
DOI DOI not available
Published Journal: Journal of Pakistan Medical Association, Volume: 66, Issue: 6, Year: 2016

Request the full text from PASTIC

0

Citations

0

Downloads

176

Views